▶ China Insulin Market Analysis to 2018 - Research Report by Ken Research - Video Dailymotion

▶ China Insulin Market Analysis to 2018 - Research Report by Ken Research - Video Dailymotion

•           Future Growth of the insulin market will be led
  by greater consumption of analog insulin
•          Market leaders are concentrating upon R&D
  in the country

Ken
Research announced its latest publication on “China Insulin Market Review to 2018 - Increasing Focus on R&D
Investments” which provides a comprehensive analysis of major types of
insulin consumed in the country. The report covers various aspects such as
market size of China’s insulin market, segmentation on the basis of insulin
replacement therapy, types of insulin, usage by type of diabetes and future
outlook of the market. The report is useful for insulin manufacturers and
distributors, as well as new players venturing in the market.

In view of China
accounting for the largest patient pool of diabetes in the world, in addition
to the growing spending power of the population, insulin majors such as Novo
Nordisk, Eli Lilly and Company and Sanofi are intensifying their R&D and
production activities in the country.  In
order to provide products that are more localized that suit the specific needs
of China’s diabetic population, companies are increasingly investing towards
R&D in the country.     

According to the
research report, the Chinese insulin market will grow rapidly, thereby exceeding
USD 3 billion by 2018, largely due to rapidly increasing consumption of analog
insulin in the country.

“Since China is
on its way to become the largest market for insulin in the Asia Pacific as well
as globally, insulin companies are strengthening their R&D in the country”,
according
to the Research Associate, Ken Research.

Key
Topics Covered in the Report:

-         
China Insulin Market Size by Volume and Value

-         
Market Segmentation by insulin replacement
therapy and types of insulin

-         
Trends and growth drivers   

-         
Competition and Market Share

-         
Future Outlook

-         
Macro Economic Parameters

Key
Products Mentioned in the Report

Human Insulin

Analog Insulin

Premix Insulin

Rapid Acting Insulin

Long Acting Insulin

Companies
Covered in the Report

Novo Nordisk

Eli Lilly and Company

Sanofi Aventis

BJ Ganli Pharmaceuticals

Tonghua Dongbao

Browse and Download
Report Here - http://www.kenresearch.com/healthcare/pharmaceutical-industry/china-insulin-market-research-report/574-91.html

Related Reports:

The US Diabetic Devices Industry Outlook to 2018 -
Growth to be Led by Next Generation Technology

India Diabetes Industry Research and Forecasts to
FY'2016 - Shift towards Modern Insulin Delivery Devices

The US Anti Cancer Drug
Market Outlook to 2018

Contact:

Ken Research

Information Department

info@kenresearch.com

+91-011-47017199

Healthcare Report - India Future Insulin Market Trends and Growth - Video Dailymotion

Healthcare Report - India Future Insulin Market Trends and Growth - Video Dailymotion

India Insulin Market
Review to 2018 - Intensifying Strategic Alliances Between Companies’
presents a comprehensive analysis of market size by value of major types of
insulin consumed in India. The report entails the segment wise market share
analysis and company profiles of major players in the insulin market in India.
The future analysis of the market has also been discussed in the report.

The diabetic population in India is largely treated with
human insulin solely due to the fact that it is cheaper as compared to analog
insulin. In FY’2013, human insulin held ~% of the total insulin market in India,
generating revenue of USD ~ million. The revenue from human insulin registered
a CAGR of 10.5% during FY’2008-FY’2013. Although the share of human insulin has
been more since FY’2008, the market captured by analog insulin has been growing
rapidly with a CAGR of 20.4% during FY’2008-FY’2013, increasing its share from
~% in FY’2008 to ~% in FY’2013.

India has become a very lucrative market for insulin
multinationals. Companies including Novo Nordisk, Eli Lilly and Sanofi dominate
the landscape and had a share of more than ~% in the Indian insulin market in
FY’2013. With superior product portfolios and marketing strategies, the 3
companies have gained a monopoly over the market. Domestic enterprises
including Biocon and Wockhardt therefore face stiff competition from the
foreign counterparts.

Key Topics Covered in
the Report

·        
The market size of India insulin market in terms
of revenue

·        
Market segmentation by insulin replacement
therapy and types of insulin

·        
Government regulation and support schemes for
the Indian insulin market

·        
Pricing scenario of different insulin brands in
India

·        
Trends and developments in India insulin market

·        
Growth drivers and challenges in India insulin
market

·        
Market share of major players in the insulin
market in India

·        
Market share of major players by types of
insulin

·        
Company profiles of major players in the Indian
insulin market

·        
Future outlook and projections of the insulin
market in India

Macroeconomic factors affecting the insulin
market in India   

Browse and Download Report Here - http://www.kenresearch.com/healthcare/pharmaceutical-industry/india-insulin-market-research-report/573-91.html

Contact:

Ken Research

Information Department

info@kenresearch.com

+91-011-47017199

Trends and Developments of Philippines K-12, Higher Education, Test Preparation, Technical-Vocational Training and Teacher Training Market

Philippines Education Industry Outlook to 2018 – Next Wave of Growth Driven by Test Preparation, Teacher Training and Vocational Training Segment presents a comprehensive analysis of the industry covering aspects including market size in terms of revenues, enrollments, establishments and faculty-student ratio. The report also entails a detailed analysis of the market segmentation on the basis of K-12, higher education, technical and vocational training, test preparation, private tutoring, e-learning and teacher training and education by different categories on the basis of revenues, enrollments and establishments.

The report provides the company profiles of the major players operating in the test preparation, technical-vocational training, teacher training and education, K-12, higher education and e-learning market in Philippines. The report also highlights the major trends and developments of all the segments in Philippines education industry over the years. Future analysis of the industry along with its various market segments is provided on the basis of revenues over the next five years.

Philippines education industry has showcased a significant growth in the past decade owing to the adoption of the enhanced basic education model. The financial support and aid from the foreign countries such as Australia, Canada, US and others have been aiding the Philippines government in restructuring the education system in the country. The several programs and initiatives have been taken by the Philippines government to improve the quality of education in the country. The increasing investments by the government and other local and foreign agencies for the provision of universal access to quality education at all levels to the Filipinos are likely to boost the total number of enrollments and establishments in the education industry in Philippines.

The K-12 education market has been the largest contributor to the overall revenues of the Philippines education industry. The revenues of K-12 education market were estimated to be worth USD ~ million in 2013, which grew from USD ~ million in 2008. The major growth driver in the K-12 education market was the implementation of the enhanced basic education program in Philippines. This market has been highly fragmented with the presence of large number of public and private players competing on the basis of tuition fees, infrastructure and other services. The major segments in the K-12 education market are namely kindergarten, primary and high school. Secondary level of education accounted for the majority share to the overall revenues of the K-12 education market.

The higher education market is the second largest contributor to the revenues of the Philippines education industry. The market share of the higher education market in Philippines declined to ~% in 2013. This declining market share was possibly due to the inclining tuition fees for the private and public higher education institutions. Some of the major players operating in this market are namely University of the Philippines, De La Salle University and others. This market is likely to grow at a CAGR of ~% in the next 5 years.

The technical-vocational training segment accounted for a share of ~% in 2008 which declined marginally to ~% in 2013. The major reason for this decline was the no or low fees charged by the public technical-vocational training institutions in Philippines. This market is expected to witness an increase in the revenues to USD ~ million over the period from 2013 to 2018.

The Philippines private tutoring market has contributed a share of ~% in 2008 which decreased slightly to ~% in 2013. The trend of homeschooling in Philippines can be attributed for the decline in the market share. The major players operating in the tutoring market are namely AHEAD tutorial and review center, MSA Academic Advancement Institute and others. It is expected that the private tutoring market in Philippines will grow at a CAGR of ~% during the period from 2013 to 2018.

The test preparation market has been the fifth largest market in the Philippines education industry. The market revenues for test preparation increased from USD ̴ million in 2008 to USD ~ million in 2013. The Philippines test preparation market has been dominated by the private players who compete with each other through review fees and other flexibility options in timings and scheduling classes. The significant players in the Philippines test preparation market for civil engineering review are namely Besaville Review Center, Padilla Review Center, Gillesania Review Center and others. The inclining personal disposable incomes, escalating competition have been some of the reasons for remarkable growth of this segment. This market is expected to grow at a CAGR of ~% over the period 2013-2018.

The least share has been contributed by the Philippines teacher training market in 2008. It is likely to grow gradually in the future years owing to the government initiatives and programs in this segment. The teacher education market has also been growing rapidly and is expected to maintain its growth momentum in the future years. The teacher education market has been segmented into bachelors and masters degree programs offered in the field of teacher education in Philippines.

The Philippines e-learning segment has been expanding rapidly and includes online-learning and training, software development and e-content development. This market is likely to grow at a remarkable rate in the future years.

The Philippines education industry is estimated to register escalating CAGR of ~% for the period from 2013 to 2018 with the private players established in the industry driving the enrollments in the education industry in the coming years.

Key Topics Covered in the Report

• Market Size of Philippines Education Industry, 2008-2013
• Market Segmentation of Philippines Education by K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning
• Market Size of K-12 Education Market, 2008-2013
• Market Segmentation of K-12 education Market by Kindergarten, Primary and Secondary level of education, 2008-2013
• Market Size of Higher Education Market, 2008-2013
• Market Segmentation of Higher education Market by Private and Public higher education institutions, 2008-2013
• Market Size of Test Preparation Market, 2008-2013
• Market Size of Private Tutoring Market, 2008-2013
• Market Size of Technical and Vocation Training Market, 2008-2013
• Market Size of Teacher Training Market, 2008-2013
• Market Size of Teacher Education Market, 2008-2013
• Market Segmentation of Teacher Education Market by Bachelors and Masters Degree Programs in Education, 2008-2013
• Profiles of Major Players in Philippines K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning Market 
• Trends and Developments of Philippines K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning Market
• Future Outlook and Projections of K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning Market in Philippines, 2014-2018

Browse and Download Report Here - http://www.kenresearch.com/education/learning/philippines-education-market-research-report/575-99.html

Contact: 
Ken Research
Information Department
info@kenresearch.com
+91-011-47017199

India Insulin Market will Exceeds USD 600 million by FY’2018: Ken Research

India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies presents a comprehensive analysis of market size by value of major types of insulin consumed in India. The report entails the segment wise market share analysis and company profiles of major players in the insulin market in India. The future analysis of the market has also been discussed in the report.

India Insulin Market

The economic advancement of any country is paradoxical in nature. While on one hand it increases the affluence of the masses, the other side is characterized by diseases that are accompanied by passive lifestyles. From the several diseases caused by a sedentary form of life such as cardiovascular ailments, hypertension and high blood pressure, diabetes is also increasing at an alarming rate, especially in the developing countries. India was resident to nearly 61.5 million people suffering from diabetes in 2013, which is the second largest in the world after China. The prevalence of diabetes has made it the fifth largest disease in India.

Diabetes in India is reaching epidemic proportions. Rapid cultural changes such as increasing urbanization, modified diet patterns and sedentary lifestyles among the young generation, have heightened the prevalence of diabetes in India. In 2013, while 61.5 million people suffered from diabetes in the country, another 30 million were in the pre-diabetes group. Medication for the diabetic population is the need of the hour since the disease is adding significantly to the mortality rate of India.

In FY’2008, the revenue generated by the sales of insulin in India was estimated to be USD ~ million and reached USD ~ million in FY’2013, following at a CAGR of 13.9% during the period. The Indian insulin market is witnessing development and has yet to mature. With a huge base of diabetic patients, it is anticipated that only 25% of this population is receiving treatment. Unawareness backed by low affordability has left the major proportion of the diabetic populace to remain untreated. However, since higher disposable income is increasing the accessibility to healthcare services, enhanced diagnostics will further broaden the patient base, creating opportunities for insulin companies operating in India.

The diabetic population in India is largely treated with human insulin solely due to the fact that it is cheaper as compared to analog insulin. In FY’2013, human insulin held ~% of the total insulin market in India, generating revenue of USD ~ million. The revenue from human insulin registered a CAGR of 10.5% during FY’2008-FY’2013. Although the share of human insulin has been more since FY’2008, the market captured by analog insulin has been growing rapidly with a CAGR of 20.4% during FY’2008-FY’2013, increasing its share from ~% in FY’2008 to ~% in FY’2013.

India has become a very lucrative market for insulin multinationals. Companies including Novo Nordisk, Eli Lilly and Sanofi dominate the landscape and had a share of more than ~% in the Indian insulin market in FY’2013. With superior product portfolios and marketing strategies, the 3 companies have gained a monopoly over the market. Domestic enterprises including Biocon and Wockhardt therefore face stiff competition from the foreign counterparts.

Key Topics Covered in the Report

·         The market size of India insulin market in terms of revenue

·         Market segmentation by insulin replacement therapy and types of insulin

·         Government regulation and support schemes for the Indian insulin market

·         Pricing scenario of different insulin brands in India

·         Trends and developments in India insulin market

·         Growth drivers and challenges in India insulin market

·         Market share of major players in the insulin market in India

·         Market share of major players by types of insulin

·         Company profiles of major players in the Indian insulin market

·         Future outlook and projections of the insulin market in India

·         Macroeconomic factors affecting the insulin market in India   

Table of Contents:

1. Asia Pacific Insulin Market Introduction

1.1. Asia Pacific Insulin Market Value Chain

1.2. Asia Pacific Insulin Market Size by Value, 2008-2013

1.3. Asia Pacific Insulin Market Segmentation, 2008-2013

1.3.1. By Geography, 2008-2013

1.3.2. By Insulin Replacement Therapy (Human Insulin and Analog Insulin), 2013

1.3.3. By Types of Insulin (Premix, Rapid Acting, Long Acting), 2013

1.4. New Product Development By Major Insulin Companies

1.5. Trends and Developments in Asia Pacific Insulin Market

Monopoly of Foreign Brands

Phasing Out of Human Insulin

1.6. Growth Drivers and Challenges in Asia Pacific Insulin Market

Shift from Human Insulin to Analog Insulin

Rising Prevalence of Diabetes

Increasing Diabetes Care Expenditure

Low Affordability

Lack of Awareness

1.7. SWOT Analysis of Asia Insulin Market

1.8. Asia Pacific Insulin Market Future Outlook and Projections, 2014-2018

1.8.1. By Geography, 2014-2018

2. India Insulin Market Introduction

3. India Insulin Market Size, FY’2008-FY’2013

4. India Insulin Market Segmentation, FY’2008-FY’2013

4.1. By Insulin Replacement Therapy (Human Insulin and Analog Insulin), FY’2008-FY’2013

4.2. By Types of Insulin (Premix, Rapid Acting, long Acting), FY’2008-FY’2013

4.3. Usage by Type of Diabetes, FY’2008-FY’2013

5. Government Regulations and Support Schemes in India Insulin Market

5.1. National Pharmaceutical Pricing Authority (NPPA) 

Implications of Pricing Limits by NPPA

5.2. National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) 

6. Pricing Scenario in India Insulin Market

7. Trends and Developments in India Insulin Market

Price Gap Between Foreign and Domestic Insulin Brands

Shift of Diabetes to Young Age Group

Strategic Alliances in India Insulin Market

8. Growth Drivers and Challenges in India Insulin Market

Increasing Diabetic Population

Increasing Expenditure on Diabetes Care

Exchange Rate Fluctuation

9. Market Share of Major Companies in India Insulin Market, FY’2013

9.1. By Type of Insulin, FY’2013

9.1.1. By Premix Insulin, FY’2013

9.1.2. By Long Acting Insulin, FY’2013

9.1.3. By Rapid Acting Insulin, FY’2013

10. Company Profiles of Major Players in India Insulin Market

10.1. Novo Nordisk India Pvt. Ltd

10.1.1. Company Overview

10.1.2. Business Strategies

Market Expansion Through Spreading Awareness

Strengthening Research and Development (R&D) Activities

10.1.3. Competitive Standing

10.2. Eli Lilly and Company India Pvt. Ltd. 

10.2.1. Company Overview

10.2.2. Business Strategies

Focus on Increasing R&D Investment in India

Concentration Towards the Diabetes Care Segment

10.2.3. Competitive Standing

10.3. Sanofi India Ltd. 

10.3.1. Company Overview

10.3.2. Business Strategies

Commence Insulin Production in India

Product Innovation

Patient Awareness Programs

10.3.3. Competitive Standing

10.4. Biocon Ltd. 

10.4.1. Company Overview

10.4.2. Competitive Standing

10.5. Wockhardt Ltd. 

10.5.1. Company Overview

10.5.2. Competitive Standing

11. India Insulin Market Future Outlook and Projections, 2014-2018

11.1. By Insulin Replacement Therapy (Human Insulin and Analog Insulin, FY’2014-FY’2018

11.2. Cause and Effect Relationship Between Dependable and Independent Variable Factors prevailing in India Insulin Market

12. Macroeconomic Factors in India Insulin Market, 2008-2018

12.1. Diabetic Population in India, 2008-2018

12.2. India Government Spending on Healthcare, FY’2008-FY’2018

12.3. India Consumer Spending on Healthcare, FY’2008-FY’2018

12.4. India Personal Disposable Income, FY’2008-FY’2018

13. Appendix

13.1. Market Definitions

13.2. Abbreviations

13.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent) 

Final Conclusion

13.4. Disclaimer

Browse and Download Report Here - http://www.kenresearch.com/healthcare/pharmaceutical-industry/india-insulin-market-research-report/573-91.html

Contact:
Ken Research
Information Department
info@kenresearch.com
+91-011-47017199

Market Size of Asia Pacific Insulin Market by Location India, China and Japan

·         Asia Pacific insulin market is expected to reach more than USD 10 Billion by 2018

·         Future Growth of the insulin market will be led by greater consumption of the long acting insulin

·         Market leaders are anticipated to maintain focus on expanding R&D facilities and distribution network in emerging markets of China and India

Ken Research announced its latest publication on “Asia Pacific Insulin Market Review to 2018” which provides a comprehensive analysis of major countries and types of insulin consumed in the region. The report covers various aspects such as market size of Asia Pacific insulin market, segmentation on the basis of geographies (China, India and Japan) and future outlook of the market. The report is useful for insulin manufacturers and distributors, as well as new players venturing in the market.

Asia Pacific insulin market

Diabetes is spreading more rapidly in Asia Pacific than any other region in the world. It is a perceived notion that unlike the western countries where diabetes affects older people, in Asia Pacific, the disease is disproportionately high in young to middle-aged adults. Insulin, the basis of diabetes treatment has witnessed a surge in demand in the past decade. Factors such as growing diabetic population, increasing expenditure on healthcare both by the consumers and the government, expanding distribution network and high scope in developing economies such as China and India poses to be potential drivers for the insulin market in Asia Pacific region. The market registered a CAGR of 13.9% during 2008-2013.

According to the research report, the Asia Pacific insulin market will grow at an impressive CAGR, thereby exceeding USD 10 billion by 2018, largely due to increasing incidence of diabetes and rising healthcare expenditure both by the government and the consumers.

“Although lack of diabetes care awareness and low affordability will hinder the growth of the insulin market in the Asia Pacific, rising disposable income of the population and diagnosis of diabetes will cater to increasing consumption of insulin in the region”, according to the Research Associate, Ken Research.

Key Topics Covered in the Report:

-          Asia Pacific Insulin Market Size by Revenue

-          Market Segmentation by Geographies (China, India, Japan)

-          Trends, Growth Drivers and Issues   

-          Country wise market size and segmentation

-          Competition and Market Share

-          Future Outlook

-          Macro Economic Parameters

Key Products Mentioned in the Report

Human Insulin

Analog Insulin

Premix Insulin

Rapid Acting Insulin

Long Acting Insulin

Companies Covered in the Report

Novo Nordisk

Eli Lilly and Company

Sanofi Aventis

Biocon

Wockhardt

BJ Ganli Pharmaceuticals

Tonghua Dongbao

Browse and Download Report Here- http://www.kenresearch.com/healthcare/pharmaceutical-industry/asia-pacific-insulin-market-research-report/572-91.html

Related Reports:

The US Diabetic Devices Industry Outlook to 2018 - Growth to be Led by Next Generation Technology

India Diabetes Industry Research and Forecasts to FY'2016 - Shift towards Modern Insulin Delivery Devices

The US Anti Cancer Drug Market Outlook to 2018

Contact: 

Ken Research
Information Department
info@kenresearch.com
+91-011-47017199

Future outlook and projections for Brazil Nuclear Power Generation Equipments Market

·         Nuclear Power Generation Equipments Market Value in Brazil is expected to reach USD 7.9 Billion by 2030

·         Policies and Regulatory Framework in Brazil to favor Nuclear Power Sector & Generation Equipments Market

·         The players engaged in nuclear power plant equipments entering into contracts with the Brazilian regulatory authorities

Ken Research announced its latest publication on “Brazil Nuclear Power Generation and Equipments Market Outlook to 2030” which provides a comprehensive analysis of the Nuclear Power Generation Equipments market in Brazil covering various aspects such as market size, market segmentation on the basis of major equipment types such as nuclear island equipments and conventional islands equipments, trends, growth drivers, challenges, expected future developments, facts about planned nuclear power plant projects and future projections of the market value of nuclear power generation equipments. The report also provides detailed explanation of the various macro variables and industry factors impacting the growth of Brazilian nuclear power generation equipments market.

Brazil Nuclear Power Market 

The market value of equipments and planned nuclear reactors are going to be major drivers of the equipment market. The Brazilian nuclear power generation equipments market is comprised of major global companies such as Areva and Westinghouse Electric which possess good nuclear reactors equipments portfolio as wholly owned and through joint ventures at major nuclear energy generation regions.

According to the research report, the market value of nuclear power generation equipments will reach approx. USD 8 billion by 2030 due to the planned power plants and increasing electricity demand. The upcoming NPPs particularly Angra 3 is likely to escalate nuclear energy consumption to 4.3 Mtoe in 2018 from 3.3 Mtoe in 2013.

“Due to over dependence on hydroelectricity since years, the power generation industry in Brazil is looking beyond traditional methods of electricity generation. This is the stepping stone for nuclear power generation industry, which has the potential to satisfy the rising electricity demand in Brazil. Therefore, there is an excellent opportunity for nuclear power generation equipments companies to leverage their expertise in nuclear technology. However, a few major challenges such as policy regulations, environmental concerns, uranium spot prices volatility and presence of natural gas as alternative in energy portfolio of Brazilian economy which might affect the growth of this market in the coming years”, according to the Research Analyst, Ken Research.

Key Topics Covered in the Report:

Brazil Nuclear Power Generation Equipments Market

-          Market Size by value of nuclear power generation equipments in 2013

-          Market Segmentation by

o   Nuclear Island Equipments

o   Conventional Island Equipments

-          Historic Trends and Future Development

-          Cost Analysis and Establishment Process

-          Growth Drivers

-          Policies and Regulatory Framework

-          Future Outlook and Projections

-          Macro Economic Variables

Companies Covered in the Report

Areva

Westinghouse Electric

Alstom

Nuclebras Heavy Equipment (NUCLEP)

Industrias Nucleares Do Brasil S.A. (INB)

Eletrobras Termonuclear S.A

Browse and Download Report Here- http://www.kenresearch.com/energy-and-utilities/clean-technology-industry-/brazil-nuclear-power-market-research-report/571-103.html

Related Reports:

Norway Offshore Drilling Industry Outlook to 2018 - Petroleum Investments in Norwegian Continental Shelf to Drive the Industry

Europe Fuel Cell Market Outlook to 2018 - Integration of Hydrogen in Fuel Cells to Drive Commercialization

Europe Biofuel Market Outlook to 2016 - Compelling Potential in Bio Diesel Segment

Contact:
Ken Research
Information Department
info@kenresearch.com
+91-11-47017199